Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB-ALIP vs NITISINONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRSEVIMAB-ALIP vs NITISINONE: Safety Overview

Metric NIRSEVIMAB-ALIP NITISINONE
Total FAERS Reports 783 752
Deaths Reported 32 96
Death Rate 4.1% 12.8%
Hospitalizations 281 198
Average Patient Age 3.3 yrs 18.6 yrs
% Female Patients 46.3% 45.2%
FDA Approval Date N/A Apr 22, 2016
Manufacturer N/A Bryant Ranch Prepack
Route N/A ORAL
Marketing Status Prescription Prescription